Alliancebernstein L.P. Replimune Group, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Replimune Group, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 51,490 shares of REPL stock, worth $527,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,490

Previous 142,001 63.74%

Holding current value

$527,772

Previous $1.38 Million 65.46%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.92 - $10.38 $626,336 - $939,504	-90,511 Reduced 63.74%	51,490 $478,000
Q1 2025 May 15, 2025	SELL	$9.75 - $14.31 $2.91 Million - $4.27 Million	-298,611 Reduced 67.77%	142,001 $1.38 Million
Q4 2024 Feb 12, 2025	SELL	$10.54 - $14.93 $510,104 - $722,567	-48,397 Reduced 9.9%	440,612 $5.34 Million
Q3 2024 Nov 14, 2024	BUY	$8.09 - $11.23 $3.41 Million - $4.73 Million	421,029 Added 619.34%	489,009 $5.36 Million
Q2 2024 Aug 14, 2024	BUY	$5.01 - $9.46 $106,462 - $201,025	21,250 Added 45.47%	67,980 $611,000
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $780,394 - $1.87 Million	-115,614 Reduced 71.22%	46,730 $393,000
Q3 2023 Nov 14, 2023	BUY	$15.96 - $22.18 $1.85 Million - $2.56 Million	115,614 Added 247.41%	162,344 $2.78 Million
Q2 2023 Aug 15, 2023	BUY	$15.65 - $24.1 $150,255 - $231,384	9,601 Added 25.86%	46,730 $1.09 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $92,644 - $154,177	5,300 Added 16.65%	37,129 $655,000
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $17,585 - $28,719	1,029 Added 3.34%	31,829 $865,000
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $54,612 - $81,918	4,100 Added 15.36%	30,800 $538,000
Q3 2021 Nov 10, 2021	SELL	$28.98 - $39.54 $78,246 - $106,758	-2,700 Reduced 9.18%	26,700 $791,000
Q2 2021 Jul 30, 2021	BUY	$28.5 - $39.37 $367,650 - $507,872	12,900 Added 78.18%	29,400 $1.13 Million
Q1 2021 May 06, 2021	SELL	$30.22 - $45.57 $253,848 - $382,788	-8,400 Reduced 33.73%	16,500 $503,000
Q4 2020 Feb 08, 2021	BUY	$23.5 - $52.65 $9,400 - $21,060	400 Added 1.63%	24,900 $950,000
Q3 2020 Nov 12, 2020	SELL	$18.85 - $27.0 $24,505 - $35,100	-1,300 Reduced 5.04%	24,500 $564,000
Q2 2020 Aug 13, 2020	BUY	$9.76 - $25.95 $70,272 - $186,840	7,200 Added 38.71%	25,800 $641,000
Q1 2020 May 14, 2020	BUY	$8.9 - $19.08 $49,840 - $106,847	5,600 Added 43.08%	18,600 $185,000
Q4 2019 Feb 18, 2020	BUY	$11.61 - $17.21 $8,127 - $12,047	700 Added 5.69%	13,000 $187,000
Q3 2019 Nov 14, 2019	BUY	$10.01 - $16.87 $16,016 - $26,992	1,600 Added 14.95%	12,300 $171,000
Q2 2019 Aug 14, 2019	BUY	$12.51 - $17.28 $133,857 - $184,896	10,700 New	10,700 $157,000

Others Institutions Holding REPL

# of Institutions

196

Shares Held

77.6M

Call Options Held

2.06M

Put Options Held

2.86M

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $505M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Replimune Group, Inc. Transaction History